Literature DB >> 13931962

Thiotepa in treatment of advanced breast cancer.

A LYONS, G EDELSTYN.   

Abstract

Entities:  

Keywords:  BREAST NEOPLASMS; THIO-TEPA

Mesh:

Substances:

Year:  1962        PMID: 13931962      PMCID: PMC1926634          DOI: 10.1136/bmj.2.5315.1280

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  6 in total

1.  Toxic marrow failure after treatment of carcinoma with cytotoxic drugs.

Authors:  I C CREE
Journal:  Br Med J       Date:  1960-11-19

2.  Breast cancer; a new approach to therapy.

Authors:  G W WATSON; R L TURNER
Journal:  Br Med J       Date:  1959-05-23

3.  Factors influencing response to hypophysectomy for advanced cancer of breast.

Authors:  A MCCALISTER; R B WELBOURN; G J EDELSTYN; A R LYONS; A R TAYLOR; C A GLEADHILL; D S GORDON; J O COLE
Journal:  Br Med J       Date:  1961-03-04

4.  Adrenalectomy and hypophysectomy for advanced cancer of the breast.

Authors:  H J ATKINS; M A FALCONER; J L HAYWARD; K S MACLEAN; P H SCHURR; P ARMITAGE
Journal:  Lancet       Date:  1960-05-28       Impact factor: 79.321

5.  Toxic marrow failure treated by a homograft of foetal haemopoietic tissue.

Authors:  J B BRIDGES; J M BRIDGES; G J EDELSTYN; A R LYONS; M G NELSON
Journal:  Lancet       Date:  1960-03-19       Impact factor: 79.321

6.  Hypophysectomy combined with intrasellar irradiation with yttrium-90.

Authors:  G A EDELSTYN; C A GLEADHILL; A R LYONS; H W RODGERS; A R TAYLOR; R B WELBOURN
Journal:  Lancet       Date:  1958-03-01       Impact factor: 79.321

  6 in total
  2 in total

1.  Thiotepa in the treatment of advanced breast cancer.

Authors:  A R Lyons; G A Edelstyn
Journal:  Br J Cancer       Date:  1965-09       Impact factor: 7.640

Review 2.  Drug repurposing for breast cancer therapy: Old weapon for new battle.

Authors:  Sadhna Aggarwal; Sumit Singh Verma; Sumit Aggarwal; Subash Chandra Gupta
Journal:  Semin Cancer Biol       Date:  2019-09-21       Impact factor: 15.707

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.